Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenerative Medical Technology (RMTG) Shares Outstanding (Diluted Average) (2018 - 2025)

Historic Shares Outstanding (Diluted Average) for Regenerative Medical Technology (RMTG) over the last 7 years, with Q3 2025 value amounting to $12.5 million.

  • Regenerative Medical Technology's Shares Outstanding (Diluted Average) changed 0.0% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $12.5 million for FY2024, which is 67.88% up from last year.
  • Latest data reveals that Regenerative Medical Technology reported Shares Outstanding (Diluted Average) of $12.5 million as of Q3 2025, which was down 0.0% from $12.5 million recorded in Q2 2025.
  • Over the past 5 years, Regenerative Medical Technology's Shares Outstanding (Diluted Average) peaked at $12.5 million during Q3 2024, and registered a low of $10.9 million during Q2 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $12.3 million, with a median of $12.4 million in 2023.
  • As far as peak fluctuations go, Regenerative Medical Technology's Shares Outstanding (Diluted Average) skyrocketed by 1175.07% in 2022, and later changed by 0.0% in 2025.
  • Quarter analysis of 5 years shows Regenerative Medical Technology's Shares Outstanding (Diluted Average) stood at $11.5 million in 2021, then increased by 6.42% to $12.2 million in 2022, then rose by 1.86% to $12.4 million in 2023, then grew by 0.68% to $12.5 million in 2024, then rose by 0.06% to $12.5 million in 2025.
  • Its last three reported values are $12.5 million in Q3 2025, $12.5 million for Q2 2025, and $12.5 million during Q1 2025.